Header cover image

Hong Kong (HSI) Biotech Industry Analysis

UpdatedSep 02, 2024
DataAggregated Company Financials
Companies49
  • 7D2.5%
  • 3M-1.6%
  • 1Y-25.9%
  • YTD-17.9%

In the last week, the Biotech industry is up 2.5%, with Akeso up 7.0%. In contrast, the industry has lost 26% in the last 12 months. Earnings are forecast to grow by 39% annually.

Industry Valuation and Performance

Has the Hong Kong Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 02 Sep 2024HK$340.4bHK$52.6b-HK$19,600,279,846.7811.6x-17.4x6.5x
Wed, 31 Jul 2024HK$308.4bHK$49.7b-HK$19,491,678,475.6511.3x-15.8x6.2x
Fri, 28 Jun 2024HK$333.2bHK$49.6b-HK$19,437,291,027.9812.1x-17.1x6.7x
Sun, 26 May 2024HK$344.5bHK$49.8b-HK$19,517,236,241.0211.7x-17.7x6.9x
Tue, 23 Apr 2024HK$315.9bHK$49.5b-HK$19,910,409,871.6210.8x-15.9x6.4x
Thu, 21 Mar 2024HK$363.4bHK$47.8b-HK$20,968,633,010.9617.5x-17.3x7.6x
Sat, 17 Feb 2024HK$337.6bHK$47.2b-HK$20,382,504,617.3516.3x-16.6x7.2x
Mon, 15 Jan 2024HK$381.0bHK$46.9b-HK$20,252,418,110.0017.7x-18.8x8.1x
Wed, 13 Dec 2023HK$401.1bHK$46.8b-HK$20,200,802,361.0017.9x-19.9x8.6x
Fri, 10 Nov 2023HK$421.8bHK$45.2b-HK$18,930,524,594.0013.5x-22.3x9.3x
Sun, 08 Oct 2023HK$388.5bHK$45.0b-HK$19,137,116,705.0013.8x-20.3x8.6x
Tue, 05 Sep 2023HK$412.3bHK$45.1b-HK$16,929,241,645.0015.1x-24.4x9.1x
Thu, 03 Aug 2023HK$397.0bHK$35.5b-HK$23,337,130,199.0022x-17x11.2x
Sat, 01 Jul 2023HK$391.5bHK$35.2b-HK$23,144,115,321.0025.3x-16.9x11.1x
Mon, 29 May 2023HK$418.5bHK$36.0b-HK$23,771,398,625.0029.5x-17.6x11.6x
Wed, 26 Apr 2023HK$437.1bHK$36.8b-HK$24,032,083,790.0018.6x-18.2x11.9x
Fri, 24 Mar 2023HK$429.7bHK$35.0b-HK$36,661,632,123.0022.5x-11.7x12.3x
Sun, 19 Feb 2023HK$415.4bHK$34.6b-HK$34,907,192,228.0032.6x-11.9x12x
Tue, 17 Jan 2023HK$468.0bHK$35.0b-HK$35,421,330,962.0032.6x-13.2x13.4x
Thu, 15 Dec 2022HK$402.8bHK$33.6b-HK$33,929,185,420.0025.7x-11.9x12x
Sat, 12 Nov 2022HK$351.8bHK$33.7b-HK$32,367,923,461.0017.3x-10.9x10.5x
Mon, 10 Oct 2022HK$296.0bHK$34.0b-HK$32,532,101,794.0016.4x-9.1x8.7x
Wed, 07 Sep 2022HK$320.5bHK$34.4b-HK$33,730,074,655.0016.5x-9.5x9.3x
Fri, 05 Aug 2022HK$321.0bHK$32.8b-HK$46,309,057,875.0012.1x-6.9x9.8x
Sun, 03 Jul 2022HK$368.6bHK$33.1b-HK$46,627,164,079.0015.1x-7.9x11.1x
Tue, 31 May 2022HK$321.7bHK$34.1b-HK$45,954,938,846.0013x-7x9.4x
Thu, 28 Apr 2022HK$319.9bHK$35.6b-HK$45,008,839,288.0012.8x-7.1x9x
Sat, 26 Mar 2022HK$334.0bHK$36.1b-HK$38,675,782,158.0013.4x-8.6x9.3x
Mon, 21 Feb 2022HK$315.1bHK$31.3b-HK$32,034,553,209.0012.4x-9.8x10.1x
Wed, 19 Jan 2022HK$381.4bHK$31.1b-HK$31,891,209,285.0013.2x-12x12.2x
Fri, 17 Dec 2021HK$442.9bHK$31.1b-HK$31,844,824,921.0013.4x-13.9x14.2x
Sun, 14 Nov 2021HK$489.1bHK$31.0b-HK$31,744,501,684.0014.4x-15.4x15.8x
Tue, 12 Oct 2021HK$498.7bHK$30.5b-HK$31,547,002,088.0014.8x-15.8x16.3x
Thu, 09 Sep 2021HK$520.3bHK$30.4b-HK$31,412,511,864.3917.5x-16.6x17.1x
Price to Earnings Ratio

-16.6x


Total Market Cap: HK$520.3bTotal Earnings: -HK$31,412,511,864.39Total Revenue: HK$30.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Biotech Industry Price to Earnings3Y Average -14.4x202220232024
Current Industry PE
  • Investors are pessimistic on the Hong Kong Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 10.3x is higher than the industry's current PS ratio of 6.5x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 20% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare industry?

HK Market1.07%
Healthcare4.37%
Biotech2.54%
Biotech2.54%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
9926 AkesoHK$50.307.7%
+HK$3.1b
42.9%PS21.2x
2162 Keymed BiosciencesHK$35.5011.1%
+HK$981.9m
-31.8%PS109.6x
1952 Everest MedicinesHK$21.859.0%
+HK$577.5m
17.6%PS15.3x
6855 Ascentage Pharma Group InternationalHK$33.954.8%
+HK$479.2m
44.5%PS10.6x
6826 Shanghai Haohai Biological TechnologyHK$31.656.2%
+HK$426.3m
-5.8%PE15x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

1952

HK$21.85

Everest Medicines

7D

9.0%

1Y

17.6%

1877

HK$10.86

Shanghai Junshi Biosciences

7D

-9.0%

1Y

-48.2%

1801

HK$42.40

Innovent Biologics

7D

-2.5%

1Y

22.9%

6660

HK$4.60

AIM Vaccine

7D

6.2%

1Y

-90.3%

1541

HK$7.79

ImmuneOnco Biopharmaceuticals (Shanghai)

7D

-6.7%

1Y

n/a

6855

HK$33.95

Ascentage Pharma Group International

7D

4.8%

1Y

44.5%

2162

HK$35.50

Keymed Biosciences

7D

11.1%

1Y

-31.8%

2616

HK$1.58

CStone Pharmaceuticals

7D

15.3%

1Y

-29.5%

9995

HK$12.00

RemeGen

7D

-3.1%

1Y

-66.2%

6826

HK$31.65

Shanghai Haohai Biological Technology

7D

6.2%

1Y

-5.8%

6978

HK$2.75

Immunotech Biopharm

7D

-8.3%

1Y

-42.5%

2480

HK$20.00

Beijing Luzhu Biotechnology

7D

-11.9%

1Y

-37.4%

2105

HK$4.90

Laekna

7D

-7.9%

1Y

-71.3%